Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1651 - 1675 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Diacylglycerophosphoinositolglycans LMGP15010278
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:1(9Z)/14:0)
126457646 1794.842783 C78H139O43P
Gangliosides LMSP0601AK08
  • GD3(d18:1/26:1(17Z))
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262051 1581.949432 C78H139N3O29
Gangliosides LMSP0601AN02
  • GD2(d18:1/18:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262069 87516 1674.919256 C78H138N4O34
Gangliosides LMSP0601DE01
  • KDNGD1a(d18:1/16:0)
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262588 1726.887683 C78H138N2O39
Gangliosides LMSP0601DI01
  • KDN GD1a 2(d18:1/16:0)
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262620 1726.887683 C78H138N2O39
Diacylglycerophosphoinositolglycans LMGP15010251
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(17:0/16:2(9Z,12Z))
126457619 1792.827133 C78H137O43P
Diacylglycerophosphoinositolglycans LMGP15010284
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(19:2(9Z,12Z)/14:0)
126457652 1792.827133 C78H137O43P
Gangliosides LMSP0601DD05
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262584 1588.944013 C77H140N2O31
Gangliosides LMSP0601DF05
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • KDN-GM1(d18:1/24:0)
44262600 1588.944013 C77H140N2O31
Gangliosides LMSP0601EB05
  • KDN-lactotetraosylceramide(d18:1/24:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262760 1588.944013 C77H140N2O31
Gangliosides LMSP0601EC05
  • KDN(2-6)lactotetraosylceramide(d18:1/24:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262768 1588.944013 C77H140N2O31
Gangliosides LMSP0601GE05
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263168 1588.944013 C77H140N2O31
Gangliosides LMSP0601GG05
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/24:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263184 1588.944013 C77H140N2O31
Diacylglycerophosphoinositolglycans LMGP15010243
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(16:0/16:0)
126457611 1782.842783 C77H139O43P
Diacylglycerophosphoinositolglycans LMGP15010254
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:0/14:0)
126457622 1782.842783 C77H139O43P
Gangliosides LMSP0601BY04
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262367 1617.934177 C77H139N3O32
Gangliosides LMSP0601CJ04
  • Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262439 1617.934177 C77H139N3O32
Gangliosides LMSP0601FF04
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262983 1617.934177 C77H139N3O32
Gangliosides LMSP0601AH04
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262023 1601.939262 C77H139N3O31
Gangliosides LMSP0601AP04
  • GM1(d18:1/22:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262087 1601.939262 C77H139N3O31
Gangliosides LMSP0601AY04
  • GM1b(d18:1/22:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262159 1601.939262 C77H139N3O31
Gangliosides LMSP0601BM04
  • GM1alpha(d18:1/22:0)
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262271 1601.939262 C77H139N3O31
Gangliosides LMSP0601DK04
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • sialyl-lactotetraosylceramide(d18:1/22:0)
44262631 1601.939262 C77H139N3O31
Gangliosides LMSP0601DY04
  • NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • sialyl(2-6)lactotetraosylceramide(d18:1/22:0)
44262735 1601.939262 C77H139N3O31
Gangliosides LMSP0601DZ04
  • Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262743 1601.939262 C77H139N3O31

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024